MedTechHub · Lab & Hospital Equipment · North America

North America Industrial Centrifuge Market: Market Size & Forecast 2026

The North America industrial centrifuge market encompasses equipment used across biopharmaceutical manufacturing, chemical processing, food and beverage production, wastewater treatment, and uranium enrichment. Valued at approximately $4.5 billion in 2025, the market is expanding rapidly at a compound annual growth rate of 26.8 percent, fueled by bioprocessing capacity expansions, supply chain localization efforts in energy sectors, and tightening environmental regulations. Key demand drivers include the region's dominant position in global bioprocessing, pharmaceutical CDMO growth, and industrial waste management mandates.

Market size · 2025
$4.5 billion
CAGR · 2025–2030
26.8%
Forecast · 2030
$14.8 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $4.5bn2030 est: $14.8bn
Read the full North America Industrial Centrifuge Market report →

Market Overview

Industrial centrifuges separate solids from liquids or liquids from liquids using centrifugal force, serving industries from biotechnology to agriculture. North America commands a leading position in this sector, holding approximately 40 percent of the global bioprocessing equipment market and 38 percent of laboratory automation systems that integrate centrifugation modules. The market spans laboratory-scale devices to large continuous-flow decanters processing thousands of liters per batch.

  • Market valued at approximately $4.5 billion in 2025 with a projected CAGR of 26.8 percent through the early 2030s
  • North America holds roughly 38-40 percent share of global bioprocessing and laboratory automation markets reliant on centrifugation
  • Applications span biopharmaceutical manufacturing, food processing, wastewater treatment, mining, and uranium enrichment

Growth Drivers

The biopharmaceutical sector represents the largest demand catalyst, driven by monoclonal antibody, vaccine, and cell therapy production requiring high-throughput centrifugation for cell harvesting and purification. Supply chain reshoring in the nuclear fuel sector is accelerating centrifuge demand as North American uranium enrichment infrastructure diversifies away from legacy foreign suppliers. Agricultural and environmental regulations mandating improved solid-liquid separation in waste management are expanding the market for decanter centrifuges in dairy and livestock operations.

  • Pharmaceutical CDMO capacity expansion and cell therapy manufacturing scaling requiring industrial-scale centrifuges processing hundreds to thousands of liters of cell broth
  • North American nuclear utilities pursuing domestic centrifuge enrichment capability to reduce dependence on foreign-sourced uranium
  • NRCS guidelines and environmental regulations driving adoption of decanter centrifuge technology for agricultural waste and industrial wastewater treatment
Want a deeper cut on North America Industrial Centrifuge Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

By product type, the market includes disc-stack centrifuges dominant in biopharma, decanter centrifuges for industrial solids separation, tubular-bowl centrifuges for beverage and oil processing, and ultracentrifuges for research laboratories. Geographically, the United States leads North American demand due to its concentration of pharmaceutical manufacturing, biotechnology firms, and utility-scale enrichment facilities, while Canada contributes notably through its mining and agricultural sectors. The cold-chain and life sciences equipment segment is particularly strong, supported by North America's 40 percent-plus share of global bioprocessing activity.

  • Bioprocessing and pharmaceuticals account for the largest application segment, followed by chemical processing and environmental/wastewater treatment
  • United States represents the primary market, driven by pharmaceutical manufacturing hubs and nuclear energy infrastructure; Canada significant in mining and agriculture
  • High-value downstream sectors including cosmetics and extracellular-vesicle research are emerging as specialized centrifuge markets through 2030

Trends and Outlook

What are the recent trends and outlook?

Digitalization and process intensification are shaping centrifuge development, with manufacturers embedding sensors, automated cleaning-in-place systems, and data analytics platforms to support continuous manufacturing and Industry 4.0 standards. Single-use and modular centrifugation systems are gaining traction in biopharmaceutical fill-finish operations to reduce cross-contamination risk and accelerate changeovers. Energy efficiency improvements and heat-recovery integration align with broader industrial decarbonization goals, while the continued expansion of biomanufacturing capacity and domestic uranium enrichment suggests sustained above-market growth through the decade.

  • Continuous bioprocessing and single-use centrifugation technologies expanding in pharmaceutical CDMO and vaccine manufacturing facilities
  • Energy optimization and thermal integration with industrial heat pump systems emerging as design priorities for large-scale continuous centrifuges
  • Market projected to maintain strong double-digit growth through 2030 as bioprocessing, domestic nuclear supply chains, and environmental compliance requirements scale
Talk to a Claight analyst
Do you want to research North America Industrial Centrifuge Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.